United States Gemcitabine Hydrochloride Market Report 2016

November 2016 | 117 pages | ID: U1D786C2516EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Gemcitabine Hydrochloride

Revenue, means the sales value of Gemcitabine Hydrochloride

This report studies sales (consumption) of Gemcitabine Hydrochloride in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• AFINE CHEMICALS
• Arch Pharmalabs
• Eli Lilly
• Fresenius Kabi
• INTAS PHARMACEUTICALS
• JARI PHARMACEUTICAL
• Jiangsu Hansoh
• NINGBO TEAM
• ScinoPharm Taiwan
• Sun Pharmaceutical
• Sunray Pharmaceutical
• Tecoland
• Teva Group
• Zhejiang Hisun

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Gemcitabine Hydrochloride in each application, can be divided into

• Lung Cancer
• Pancreatic Cancer
• Bladder Cancer
• Breast cancer
• Other tumors

Contents

United States Gemcitabine Hydrochloride Market Report 2016

1 GEMCITABINE HYDROCHLORIDE OVERVIEW

1.1 Product Overview and Scope of Gemcitabine Hydrochloride
1.2 Classification of Gemcitabine Hydrochloride
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Gemcitabine Hydrochloride
  1.3.1 Lung Cancer
  1.3.2 Pancreatic Cancer
  1.3.3 Bladder Cancer
  1.3.4 Breast cancer
  1.3.5 Other tumors
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Gemcitabine Hydrochloride (2011-2021)
  1.4.1 United States Gemcitabine Hydrochloride Sales and Growth Rate (2011-2021)
  1.4.2 United States Gemcitabine Hydrochloride Revenue and Growth Rate (2011-2021)

2 UNITED STATES GEMCITABINE HYDROCHLORIDE COMPETITION BY MANUFACTURERS

2.1 United States Gemcitabine Hydrochloride Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Gemcitabine Hydrochloride Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Gemcitabine Hydrochloride Average Price by Manufactures (2015 and 2016)
2.4 Gemcitabine Hydrochloride Market Competitive Situation and Trends
  2.4.1 Gemcitabine Hydrochloride Market Concentration Rate
  2.4.2 Gemcitabine Hydrochloride Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES GEMCITABINE HYDROCHLORIDE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Gemcitabine Hydrochloride Sales and Market Share by Type (2011-2016)
3.2 United States Gemcitabine Hydrochloride Revenue and Market Share by Type (2011-2016)
3.3 United States Gemcitabine Hydrochloride Price by Type (2011-2016)
3.4 United States Gemcitabine Hydrochloride Sales Growth Rate by Type (2011-2016)

4 UNITED STATES GEMCITABINE HYDROCHLORIDE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Gemcitabine Hydrochloride Sales and Market Share by Application (2011-2016)
4.2 United States Gemcitabine Hydrochloride Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES GEMCITABINE HYDROCHLORIDE MANUFACTURERS PROFILES/ANALYSIS

5.1 AFINE CHEMICALS
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Gemcitabine Hydrochloride Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 AFINE CHEMICALS Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Arch Pharmalabs
  5.2.2 Gemcitabine Hydrochloride Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Arch Pharmalabs Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Eli Lilly
  5.3.2 Gemcitabine Hydrochloride Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Eli Lilly Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Fresenius Kabi
  5.4.2 Gemcitabine Hydrochloride Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Fresenius Kabi Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 INTAS PHARMACEUTICALS
  5.5.2 Gemcitabine Hydrochloride Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 INTAS PHARMACEUTICALS Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 JARI PHARMACEUTICAL
  5.6.2 Gemcitabine Hydrochloride Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 JARI PHARMACEUTICAL Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Jiangsu Hansoh
  5.7.2 Gemcitabine Hydrochloride Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Jiangsu Hansoh Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 NINGBO TEAM
  5.8.2 Gemcitabine Hydrochloride Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 NINGBO TEAM Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 ScinoPharm Taiwan
  5.9.2 Gemcitabine Hydrochloride Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 ScinoPharm Taiwan Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Sun Pharmaceutical
  5.10.2 Gemcitabine Hydrochloride Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Sun Pharmaceutical Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Sunray Pharmaceutical
5.12 Tecoland
5.13 Teva Group
5.14 Zhejiang Hisun

6 GEMCITABINE HYDROCHLORIDE MANUFACTURING COST ANALYSIS

6.1 Gemcitabine Hydrochloride Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Gemcitabine Hydrochloride

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Gemcitabine Hydrochloride Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Gemcitabine Hydrochloride Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES GEMCITABINE HYDROCHLORIDE MARKET FORECAST (2016-2021)

10.1 United States Gemcitabine Hydrochloride Sales, Revenue Forecast (2016-2021)
10.2 United States Gemcitabine Hydrochloride Sales Forecast by Type (2016-2021)
10.3 United States Gemcitabine Hydrochloride Sales Forecast by Application (2016-2021)
10.4 Gemcitabine Hydrochloride Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Gemcitabine Hydrochloride
Table Classification of Gemcitabine Hydrochloride
Figure United States Sales Market Share of Gemcitabine Hydrochloride by Type in 2015
Table Application of Gemcitabine Hydrochloride
Figure United States Sales Market Share of Gemcitabine Hydrochloride by Application in 2015
Figure Lung Cancer Examples
Figure Pancreatic Cancer Examples
Figure Bladder Cancer Examples
Figure Breast cancer Examples
Figure Other tumors Examples
Figure United States Gemcitabine Hydrochloride Sales and Growth Rate (2011-2021)
Figure United States Gemcitabine Hydrochloride Revenue and Growth Rate (2011-2021)
Table United States Gemcitabine Hydrochloride Sales of Key Manufacturers (2015 and 2016)
Table United States Gemcitabine Hydrochloride Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Gemcitabine Hydrochloride Sales Share by Manufacturers
Figure 2016 Gemcitabine Hydrochloride Sales Share by Manufacturers
Table United States Gemcitabine Hydrochloride Revenue by Manufacturers (2015 and 2016)
Table United States Gemcitabine Hydrochloride Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Gemcitabine Hydrochloride Revenue Share by Manufacturers
Table 2016 United States Gemcitabine Hydrochloride Revenue Share by Manufacturers
Table United States Market Gemcitabine Hydrochloride Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Gemcitabine Hydrochloride Average Price of Key Manufacturers in 2015
Figure Gemcitabine Hydrochloride Market Share of Top 3 Manufacturers
Figure Gemcitabine Hydrochloride Market Share of Top 5 Manufacturers
Table United States Gemcitabine Hydrochloride Sales by Type (2011-2016)
Table United States Gemcitabine Hydrochloride Sales Share by Type (2011-2016)
Figure United States Gemcitabine Hydrochloride Sales Market Share by Type in 2015
Table United States Gemcitabine Hydrochloride Revenue and Market Share by Type (2011-2016)
Table United States Gemcitabine Hydrochloride Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Gemcitabine Hydrochloride by Type (2011-2016)
Table United States Gemcitabine Hydrochloride Price by Type (2011-2016)
Figure United States Gemcitabine Hydrochloride Sales Growth Rate by Type (2011-2016)
Table United States Gemcitabine Hydrochloride Sales by Application (2011-2016)
Table United States Gemcitabine Hydrochloride Sales Market Share by Application (2011-2016)
Figure United States Gemcitabine Hydrochloride Sales Market Share by Application in 2015
Table United States Gemcitabine Hydrochloride Sales Growth Rate by Application (2011-2016)
Figure United States Gemcitabine Hydrochloride Sales Growth Rate by Application (2011-2016)
Table AFINE CHEMICALS Basic Information List
Table AFINE CHEMICALS Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AFINE CHEMICALS Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table Arch Pharmalabs Basic Information List
Table Arch Pharmalabs Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arch Pharmalabs Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table Fresenius Kabi Basic Information List
Table Fresenius Kabi Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fresenius Kabi Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table INTAS PHARMACEUTICALS Basic Information List
Table INTAS PHARMACEUTICALS Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table INTAS PHARMACEUTICALS Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table JARI PHARMACEUTICAL Basic Information List
Table JARI PHARMACEUTICAL Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table JARI PHARMACEUTICAL Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table Jiangsu Hansoh Basic Information List
Table Jiangsu Hansoh Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Hansoh Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table NINGBO TEAM Basic Information List
Table NINGBO TEAM Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table NINGBO TEAM Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table ScinoPharm Taiwan Basic Information List
Table ScinoPharm Taiwan Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table ScinoPharm Taiwan Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table Sunray Pharmaceutical Basic Information List
Table Sunray Pharmaceutical Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sunray Pharmaceutical Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table Tecoland Basic Information List
Table Tecoland Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tecoland Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table Teva Group Basic Information List
Table Teva Group Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Group Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table Zhejiang Hisun Basic Information List
Table Zhejiang Hisun Gemcitabine Hydrochloride Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zhejiang Hisun Gemcitabine Hydrochloride Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gemcitabine Hydrochloride
Figure Manufacturing Process Analysis of Gemcitabine Hydrochloride
Figure Gemcitabine Hydrochloride Industrial Chain Analysis
Table Raw Materials Sources of Gemcitabine Hydrochloride Major Manufacturers in 2015
Table Major Buyers of Gemcitabine Hydrochloride
Table Distributors/Traders List
Figure United States Gemcitabine Hydrochloride Production and Growth Rate Forecast (2016-2021)
Figure United States Gemcitabine Hydrochloride Revenue and Growth Rate Forecast (2016-2021)
Table United States Gemcitabine Hydrochloride Production Forecast by Type (2016-2021)
Table United States Gemcitabine Hydrochloride Consumption Forecast by Application (2016-2021)